Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Personalized Medicine: Pharmacogenomics and Drug Development Pubmed



Mirsadeghi S1 ; Larijani B2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Acta Medica Iranica Published:2017


Abstract

Personalized medicine aims is to supply the proper drug to the proper patient within the right dose. Pharmacogenomics (PGx) is to recognize genetic variants that may influence drug efficacy and toxicity. All things considered, the fields cover a wide area, including basic drug discovery researches, the genetic origin of pharmacokinetics and pharmacodynamics, novel drug improvement, patient genetic assessment and clinical patient administration. At last, the objective of Pharmacogenomics is to anticipate a patient’s genetic response to a particular drug as a way of presenting the best possible medical treatment. By predicting the drug response of an individual, it will be possible to increase the success of therapies and decrease the incidence of adverse side effect. © 2017 Tehran University of Medical Sciences. All rights reserved.
Related Docs
1. Dna Technologies in Precision Medicine and Pharmacogenetics, Precision Medicine in Clinical Practice (2022)
2. Genomic Medicine on the Frontier of Precision Medicine, Journal of Diabetes and Metabolic Disorders (2022)
Experts (# of related papers)
Bagher Larijani (1)